{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:18:21Z","timestamp":1790032701477,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017688","name":"Guangdong Provincial Key Laboratory of Construction Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107852","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:32:39Z","timestamp":1727674359000},"page":"107852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery of the FXR\/CES2 dual modulator LE-77 for the treatment of irinotecan-induced delayed diarrhea"],"prefix":"10.1016","volume":"153","author":[{"given":"Zhijun","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bioorg.2024.107852_b0005","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide [J]","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107852_b0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2307\/3349375","article-title":"The epidemiologic transition: a theory of the epidemiology of population change [J]","volume":"49","author":"Omran","year":"1971","journal-title":"Milbank Q"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020 [J]","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.bioorg.2024.107852_b0025","doi-asserted-by":"crossref","unstructured":"Arnold M, Abnet C C, Neale R E, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer [J]. Gastroenterology, 2020, 159(1): 335-49.e15.","DOI":"10.1053\/j.gastro.2020.02.068"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/cncr.24760","article-title":"Annual report to the nation on the status of cancer, 1975\u20132006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates [J]","volume":"116","author":"Edwards","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology [J]","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Ne"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107852_b0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology [J]","volume":"20","author":"Benson","year":"2022","journal-title":"J Natl Compr Canc Ne"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107852_b0045","first-page":"211","article-title":"First-line palliative chemotherapy for colorectal cancer: a population-based analysis of delivery and outcomes in a single-payer health system [J]","volume":"36","author":"Wilson","year":"2024","journal-title":"JCO"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ijc.25369","article-title":"Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil\/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer [J]","volume":"128","author":"Ducreux","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107852_b0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2165\/00003495-199652040-00013","article-title":"Irinotecan [J]","volume":"52","author":"Wiseman","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2024.107852_b0060","unstructured":"Ogawara D, Fukuda M, Nakamura Y, et al. Life-threatening toxicity in a patient with UGT1A1*6 heterozygous polymorphism after irinotecan-based chemotherapy: a case report, F, 2014 [C]."},{"issue":"1 Suppl","key":"10.1016\/j.bioorg.2024.107852_b0065","first-page":"86","article-title":"Fatty liver and drugs: the two sides of the same coin [J]","volume":"21","author":"Miele","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"16","key":"10.1016\/j.bioorg.2024.107852_b0070","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/jnci\/83.16.1164","article-title":"Phase I Study of Weekly Intravenous Infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer [J]","volume":"83","author":"Negoro","year":"1991","journal-title":"J Natl Cancer I"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107852_b0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2005.04.040","article-title":"Role of pharmacogenetics in irinotecan therapy [J]","volume":"234","author":"De Jong","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bioorg.2024.107852_b0080","article-title":"Cisplatin and irinotecan as first-line chemotherapy for previously untreated metastatic thymic carcinoma: updated analysis [J]","volume":"11","author":"Fukuda","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107852_b0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40265-017-0741-1","article-title":"Liposomal irinotecan: a review in metastatic pancreatic adenocarcinoma [J]","volume":"77","author":"Lamb","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.toxlet.2009.11.017","article-title":"Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice [J]","volume":"192","author":"Ahowesso","year":"2010","journal-title":"Toxicol. Lett"},{"issue":"16","key":"10.1016\/j.bioorg.2024.107852_b0095","first-page":"4187","article-title":"Intracellular roles of SN-38, a Metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11 [J]","volume":"51","author":"Kawato","year":"1991","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1568011033482477","article-title":"Pharmacogenetics of irinotecan [J]","volume":"3","author":"Toffoli","year":"2003","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107852_b0105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes [J]","volume":"101","author":"Iyer","year":"1998","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107852_b0110","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(96)00457-1","article-title":"Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase [J]","volume":"52","author":"Rivory","year":"1996","journal-title":"Biochem Pharmacol"},{"issue":"14","key":"10.1016\/j.bioorg.2024.107852_b0115","first-page":"3723","article-title":"Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea [J]","volume":"54","author":"Gupta","year":"1994","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107852_b0120","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/cncr.23777","article-title":"Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics [J]","volume":"113","author":"Deeken","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107852_b0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00280-009-1138-y","article-title":"Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics\/pharmacodynamics in Japanese cancer patients [J]","volume":"66","author":"Sai","year":"2010","journal-title":"Cancer Chemoth Pharm"},{"key":"10.1016\/j.bioorg.2024.107852_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2018.10.029","article-title":"Pharmacological inhibition of bacterial \u03b2-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo [J]","volume":"139","author":"Cheng","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107852_b0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00280-019-03996-y","article-title":"Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation [J]","volume":"85","author":"Huang","year":"2020","journal-title":"Cancer Chemoth Pharm"},{"key":"10.1016\/j.bioorg.2024.107852_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108933","article-title":"Effects of inflammation on irinotecan pharmacokinetics and development of a best-fit PK model [J]","volume":"316","author":"Chityala","year":"2020","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107852_b0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00109-019-01864-z","article-title":"Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea [J]","volume":"98","author":"Lindner","year":"2020","journal-title":"J. Mol. Med"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107852_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pathophys.2017.07.002","article-title":"Irinotecan chemotherapy-induced intestinal oxidative stress: underlying causes of disturbed mucosal water and electrolyte transport [J]","volume":"24","author":"Rtibi","year":"2017","journal-title":"Pathophysiology"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107852_b0155","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00520-006-0040-y","article-title":"Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies [J]","volume":"14","author":"Gibson","year":"2006","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107852_b0160","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(14)70006-3","article-title":"Guidance on the management of diarrhoea during cancer chemotherapy [J]","volume":"15","author":"Andreyev","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107852_b0165","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s005200000220","article-title":"Control of irinotecan-induced diarrhea by octreotide after loperamide failure [J]","volume":"9","author":"Barbounis","year":"2001","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jep.2012.01.047","article-title":"Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy [J]","volume":"140","author":"Liu","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107852_b0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clcc.2011.03.003","article-title":"A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer [J]","volume":"10","author":"Kummar","year":"2011","journal-title":"Clin Colorectal Canc"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/dmdi-2014-0009","article-title":"The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect [J]","volume":"29","author":"Merali","year":"2014","journal-title":"Drug Metabol Drug Interact"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107852_b0185","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11739-023-03343-3","article-title":"The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease [J]","volume":"18","author":"Di Ciaula","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107852_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100344","article-title":"Ablation of liver Fxr results in an increased colonic mucus barrier in mice [J]","volume":"3","author":"Ijssennagger","year":"2021","journal-title":"JHEP Reports"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107852_b0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases [J]","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bioorg.2024.107852_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1000444","article-title":"Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor [J]","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.bioorg.2024.107852_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102719","article-title":"Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor [J]","volume":"54","author":"Gadaleta","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioorg.2024.107852_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.12.018","article-title":"Developments in bile salt based therapies: A critical overview [J]","volume":"161","author":"Donkers","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcf.2018.08.009","article-title":"Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis [J]","volume":"18","author":"Van De Peppel","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107852_b0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.livres.2019.01.001","article-title":"Bile acid receptors and gastrointestinal functions [J]","volume":"3","author":"Ticho","year":"2019","journal-title":"Liver Res"},{"key":"10.1016\/j.bioorg.2024.107852_b0225","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1039\/C5CC09874B","article-title":"A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples [J]","volume":"52","author":"Wang","year":"2016","journal-title":"Chem. Commun"},{"key":"10.1016\/j.bioorg.2024.107852_b0230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.06.235","article-title":"Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening [J]","volume":"137","author":"Song","year":"2019","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.bioorg.2024.107852_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104199","article-title":"Discovery of natural pentacyclic triterpenoids as potent and selective inhibitors against human carboxylesterase 1 [J]","volume":"137","author":"Song","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2024.107852_b0240","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14756366.2022.2029855","article-title":"Discovery of triterpenoids as potent dual inhibitors of pancreatic lipase and human carboxylesterase 1 [J]","volume":"37","author":"Zhang","year":"2022","journal-title":"Enzyme Inhib. Med. Chem"},{"key":"10.1016\/j.bioorg.2024.107852_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114463","article-title":"Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases[J]","volume":"263","author":"Liu","year":"2020","journal-title":"Environ. Pollut"},{"key":"10.1016\/j.bioorg.2024.107852_b0250","doi-asserted-by":"crossref","DOI":"10.1080\/10641963.2023.2205051","article-title":"Lycopene alleviates oxidative stress-induced cell injury in human vascular endothelial cells by encouraging the SIRT1\/Nrf2\/HO-1 pathway[J]","volume":"45","author":"Guo","year":"2023","journal-title":"Clin. Exp. Hypertens"},{"issue":"51","key":"10.1016\/j.bioorg.2024.107852_b0255","doi-asserted-by":"crossref","first-page":"28474","DOI":"10.1021\/acsami.5b09573","article-title":"A Two-Photon Ratiometric Fluorescent Probe for Imaging Carboxylesterase 2 in Living Cells and Tissues [J]","volume":"7","author":"Jin","year":"2015","journal-title":"Acs Appl Mater Inter"},{"key":"10.1016\/j.bioorg.2024.107852_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112856","article-title":"Design, synthesis and biological evaluation of indanone\u2013chalcone hybrids as potent and selective hCES2A inhibitors [J]","volume":"209","author":"Huo","year":"2021","journal-title":"Eur. J. Med. Chem"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107852_b0265","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1021\/ct200328p","article-title":"CHARMM Additive All-Atom Force Field for Carbohydrate Derivatives and Its Utility in Polysaccharide and Carbohydrate-Protein Modeling [J]","volume":"7","author":"Guvench","year":"2011","journal-title":"J. Chem. Theory Comput"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107852_b0270","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.chempr.2018.03.001","article-title":"Hierarchically Engineered Mesoporous Metal-Organic Frameworks toward Cell-free Immobilized Enzyme Systems [J]","volume":"4","author":"Li","year":"2018","journal-title":"Chem"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107852_b0275","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review [J]","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bioorg.2024.107852_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101344","article-title":"Functions and regulation of T cell-derived interleukin-10 [J]","volume":"44","author":"Neumann","year":"2019","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107852_b0285","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00520-014-2481-z","article-title":"Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study [J]","volume":"23","author":"Coller","year":"2015","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107852_b0290","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1097\/MIB.0000000000000204","article-title":"Intestinal Inflammation and Mucosal Barrier Function [J]","volume":"20","author":"S\u00e1nchez De Medina","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107852_b0295","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/ijms21030972","article-title":"The Integral Role of Tight Junction Proteins in the Repair of Injured Intestinal Epithelium [J]","volume":"21","author":"Slifer","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.bioorg.2024.107852_b0300","first-page":"4258035","article-title":"Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis [J]","volume":"2020","author":"Zuo","year":"2020","journal-title":"Gastroent Res Pract"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107852_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1684\/ejd.2010.1192","article-title":"Tight junctions in epidermis: from barrier to keratinization [J]","volume":"21","author":"Kazumasa","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107852_b0310","first-page":"107","article-title":"Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases [J]","volume":"31","author":"Hamamoto","year":"2023","journal-title":"Appl Immunohisto M M"},{"issue":"13","key":"10.1016\/j.bioorg.2024.107852_b0315","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation [J]","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.bioorg.2024.107852_b0320","article-title":"Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats [J]","volume":"6","author":"Atshan","year":"2024","journal-title":"CRPHAR"},{"issue":"50","key":"10.1016\/j.bioorg.2024.107852_b0325","doi-asserted-by":"crossref","first-page":"35086","DOI":"10.1074\/jbc.M803531200","article-title":"The p300 Acetylase Is Critical for Ligand-activated Farnesoid X Receptor (FXR) Induction of SHP* [J]","volume":"283","author":"Fang","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.bioorg.2024.107852_b0330","doi-asserted-by":"crossref","first-page":"S1020","DOI":"10.1016\/S0016-5085(16)33454-0","article-title":"224 Organic Solute Transporter alpha-beta (Osta-Ost\u03b2) protects small intestine from potential bile acid-induced injury [J]","volume":"150(4 Supplement 1)","author":"Ferrebee","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107852_b0335","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/dmd.111.039628","article-title":"Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2 [J]","volume":"39","author":"Wang","year":"2011","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.bioorg.2024.107852_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114463","article-title":"Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases [J]","volume":"263","author":"Liu","year":"2020","journal-title":"Environ Pollut"},{"key":"10.1016\/j.bioorg.2024.107852_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120445","article-title":"Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice [J]","volume":"296","author":"Nobre","year":"2022","journal-title":"Life Sci"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:24:21Z","timestamp":1738203861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":69,"alternative-id":["S0045206824007570"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107852","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of the FXR\/CES2 dual modulator LE-77 for the treatment of irinotecan-induced delayed diarrhea","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107852"}}